Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome

Diabetes Care

Volumn 31, Issue 7, 2008, Pages 1439-1441

  Tesauro, Manfredi ^a   Schinzari, Francesca ^b   Rovella, Valentina ^a   Melina, Domenico ^b   Mores, Nadia ^b   Barini, Angela ^b   Mettimano, Marco ^b   Lauro, Davide ^a   Iantorno, Micaela ^c   Quon, Michael J ^c   Cardillo, Carmine ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; INFLIXIMAB; INSULIN; NEUTRALIZING ANTIBODY; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CHOLESTEROL; MONOCLONAL ANTIBODY; TRIACYLGLYCEROL;

ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HUMAN; HYPERINSULINEMIA; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; TREATMENT OUTCOME; TREATMENT RESPONSE; VASODILATATION; ANALYSIS OF VARIANCE; BLOOD; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BLOOD GLUCOSE; CHOLESTEROL; HUMANS; HYPERINSULINISM; METABOLIC SYNDROME X; NITROPRUSSIDE; REFERENCE VALUES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 49649124110     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0219     Document Type: Article

References (10)

1. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
2. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNF alpha by human muscle: relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996
3. Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C: Tumor necrosis factor- alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115:245-254, 2007
4. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibu- chi K, Ito M: Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphoryla- tion. J Biol Chem 272:12257-12260, 1997
5. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A: Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277:6214 -6222, 2002
6. Hotamisligil GS, Peraldi P, Budavari A, El- lis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
7. De Keulenaer GW, Alexander RW, Ushio- Fukai M, Ishizaka N, Griendling KK: Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329:653-657, 1998
8. Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944 -948, 2006
9. Gardner CD, Eguchi S, Reynolds CM, Eguchi K, Frank GD, Motley ED: Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp Biol Med 228:836-842, 2003
10. Frank GD, Eguchi S, Motley ED: The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid Redox Signal 7:1053-1061, 2005